BioCentury | Jul 10, 2020
Finance

With an eye on ‘underserved’ Nordic biotechs, Eir raises €76M toward first fund

...NYSE:NOVO) and H. Lundbeck A/S (CSE:LUN) as well as research organizations such as medical university Karolinska Institute...
BioCentury | May 1, 2020
Distillery Therapeutics

Thioredoxin reducing enzyme inhibitors for solid tumors

...DISEASE CATEGORY: Cancer INDICATION: Colorectal cancer; head and neck cancer; lung cancer A Karolinska Institute team has...
...doi:10.1126/sciadv.aax7945 CONTACT: Brent Page, Karolinska Institute, Stockholm, Sweden; University of British Columbia, Vancouver, B.C. email: brent.page@ki.se Claire Quang Karolinska Institute Thioredoxin Signal...
BioCentury | Mar 31, 2020
Product Development

COVID roundup: Vaccine R&D from Murdoch Children’s, Cobra-Karolinska, Altimmune-Alabama

...crisis can be found at https://www.biocentury.com/coronavirus . Elizabeth S. Eaton, Staff Writer University of Alabama at Birmingham Altimmune Inc. Karolinska Institute covid-19 cov19count cov19count...
BioCentury | Mar 19, 2020
Product Development

Trials, in-hospital treatments and guidances hit snags in the wake of COVID-19

...GeNeuro's decision. The trial of the anti-HERVW antibody will begin when the testing site, the Karolinska Institute...
BioCentury | Feb 1, 2020
Preclinical News

Cellular fluorescence assay to assess allosteric modulator potency in drug discovery

...in the context of a living cell. Terenius is a professor of clinical neuroscience at Karolinska Institute...
...publication, at least one company has approached them to test compounds using FCCS. Inhua Muijrers-Chen, Associate Editor Karolinska Institute Institut...
BioCentury | Dec 19, 2019

Combined inhibition of EIF4A1 and glutaminase for pancreatic cancer

...K. et al. Nat. Commun. ; published online Nov. 13, 2019 doi:10.1038/s41467-019-13086-5 CONTACT: Ola Larsson, Karolinska Institute...
...jerry.pelletier@mcgill.ca CONTACT: Iok In Christine Chio, Columbia University Medical Center, New York, N.Y. email: ic2445@cumc.columbia.edu Claire Quang CB-839 Karolinska Institute McGill...
BioCentury | Nov 18, 2019
Company News

Biofourmis’ digital solution set for biopharmas

...at least 26 million worldwide, according to a 2017 review article from researchers at the Karolinska Institute...
BioCentury | Aug 7, 2019
Clinical News

Aug. 7 Clinical Quick Takes: Waylivra cuts triglycerides in Phase III; plus Lynparza, Moderna, Athenex and Opthea

...#), ranibizumab (Generic), Lucentis (Informal) Lynparza, olaparib (AZD2281, KU-0059436, MK-7339) OPT-302, vgx-300 Oraxol Akcea Therapeutics Inc. AstraZeneca plc Athenex Inc. Ionis Pharmaceuticals Inc. Karolinska Institute Merck...
BioCentury | Jul 18, 2019
Distillery Therapeutics

Inhibition of BACH1 or the genes it controls for metastatic lung cancer

...CONTACT: Volkan I. Sayin, University of Gothenburg, Gothenburg, Sweden email: volkan.sayin@gu.se CONTACT: Martin O. Bergo, Karolinska Institute...
BioCentury | Dec 11, 2018
Translation in Brief

Diseased oligodendrocytes

...A Karolinska Institute team has identified subsets of oligodendrocyte lineage cells that may trigger T cell immunity...
...modulate the functions of the MHCII-expressing oligodendrocyte lineages in mouse models of MS. Chris Lieu, Staff Writer Karolinska Institute Major...
Items per page:
1 - 10 of 256
BioCentury | Jul 10, 2020
Finance

With an eye on ‘underserved’ Nordic biotechs, Eir raises €76M toward first fund

...NYSE:NOVO) and H. Lundbeck A/S (CSE:LUN) as well as research organizations such as medical university Karolinska Institute...
BioCentury | May 1, 2020
Distillery Therapeutics

Thioredoxin reducing enzyme inhibitors for solid tumors

...DISEASE CATEGORY: Cancer INDICATION: Colorectal cancer; head and neck cancer; lung cancer A Karolinska Institute team has...
...doi:10.1126/sciadv.aax7945 CONTACT: Brent Page, Karolinska Institute, Stockholm, Sweden; University of British Columbia, Vancouver, B.C. email: brent.page@ki.se Claire Quang Karolinska Institute Thioredoxin Signal...
BioCentury | Mar 31, 2020
Product Development

COVID roundup: Vaccine R&D from Murdoch Children’s, Cobra-Karolinska, Altimmune-Alabama

...crisis can be found at https://www.biocentury.com/coronavirus . Elizabeth S. Eaton, Staff Writer University of Alabama at Birmingham Altimmune Inc. Karolinska Institute covid-19 cov19count cov19count...
BioCentury | Mar 19, 2020
Product Development

Trials, in-hospital treatments and guidances hit snags in the wake of COVID-19

...GeNeuro's decision. The trial of the anti-HERVW antibody will begin when the testing site, the Karolinska Institute...
BioCentury | Feb 1, 2020
Preclinical News

Cellular fluorescence assay to assess allosteric modulator potency in drug discovery

...in the context of a living cell. Terenius is a professor of clinical neuroscience at Karolinska Institute...
...publication, at least one company has approached them to test compounds using FCCS. Inhua Muijrers-Chen, Associate Editor Karolinska Institute Institut...
BioCentury | Dec 19, 2019

Combined inhibition of EIF4A1 and glutaminase for pancreatic cancer

...K. et al. Nat. Commun. ; published online Nov. 13, 2019 doi:10.1038/s41467-019-13086-5 CONTACT: Ola Larsson, Karolinska Institute...
...jerry.pelletier@mcgill.ca CONTACT: Iok In Christine Chio, Columbia University Medical Center, New York, N.Y. email: ic2445@cumc.columbia.edu Claire Quang CB-839 Karolinska Institute McGill...
BioCentury | Nov 18, 2019
Company News

Biofourmis’ digital solution set for biopharmas

...at least 26 million worldwide, according to a 2017 review article from researchers at the Karolinska Institute...
BioCentury | Aug 7, 2019
Clinical News

Aug. 7 Clinical Quick Takes: Waylivra cuts triglycerides in Phase III; plus Lynparza, Moderna, Athenex and Opthea

...#), ranibizumab (Generic), Lucentis (Informal) Lynparza, olaparib (AZD2281, KU-0059436, MK-7339) OPT-302, vgx-300 Oraxol Akcea Therapeutics Inc. AstraZeneca plc Athenex Inc. Ionis Pharmaceuticals Inc. Karolinska Institute Merck...
BioCentury | Jul 18, 2019
Distillery Therapeutics

Inhibition of BACH1 or the genes it controls for metastatic lung cancer

...CONTACT: Volkan I. Sayin, University of Gothenburg, Gothenburg, Sweden email: volkan.sayin@gu.se CONTACT: Martin O. Bergo, Karolinska Institute...
BioCentury | Dec 11, 2018
Translation in Brief

Diseased oligodendrocytes

...A Karolinska Institute team has identified subsets of oligodendrocyte lineage cells that may trigger T cell immunity...
...modulate the functions of the MHCII-expressing oligodendrocyte lineages in mouse models of MS. Chris Lieu, Staff Writer Karolinska Institute Major...
Items per page:
1 - 10 of 256